Cronos Other Operating Expenses from 2010 to 2024

CRON Stock  USD 2.08  0.01  0.48%   
Cronos Other Operating Expenses yearly trend continues to be very stable with very little volatility. Other Operating Expenses is likely to drop to about 105.3 M. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2014-03-31
Previous Quarter
43.3 M
Current Value
67.9 M
Quarterly Volatility
28.3 M
 
Yuan Drop
 
Covid
Check Cronos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cronos' main balance sheet or income statement drivers, such as Interest Expense of 27.2 M, Total Revenue of 91.6 M or Gross Profit of 12.5 M, as well as many indicators such as Price To Sales Ratio of 8.66, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cronos financial statements analysis is a perfect complement when working with Cronos Valuation or Volatility modules.
  
Check out the analysis of Cronos Correlation against competitors.

Latest Cronos' Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Cronos Group over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cronos Group. It is also known as Cronos overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Cronos' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cronos' overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Cronos Other Operating Expenses Regression Statistics

Arithmetic Mean77,334,283
Geometric Mean9,982,768
Coefficient Of Variation128.93
Mean Deviation87,815,673
Median4,922,465
Standard Deviation99,706,899
Sample Variance9941.5T
Range270.9M
R-Value0.78
Mean Square Error4228T
R-Squared0.61
Significance0.0006
Slope17,342,771
Total Sum of Squares139180.5T

Cronos Other Operating Expenses History

2024105.3 M
2023172 M
2022207.9 M
2021271.4 M
2020226.1 M
2019139.9 M
201824.8 M

About Cronos Financial Statements

Cronos investors utilize fundamental indicators, such as Other Operating Expenses, to predict how Cronos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Operating Expenses172 M105.3 M

Pair Trading with Cronos

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cronos Stock

  0.65JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.64LLY Eli Lilly Sell-off TrendPairCorr

Moving against Cronos Stock

  0.56NAMS NewAmsterdam PharmaPairCorr
  0.53BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.49GILD Gilead SciencesPairCorr
The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:
Check out the analysis of Cronos Correlation against competitors.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.144
Earnings Share
(0.12)
Revenue Per Share
0.267
Quarterly Revenue Growth
0.46
Return On Assets
(0.04)
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.